In the News

Aggressive glucose control may not improve micro-, macrovascular outcomes in type 2 diabetes

Aggressive glucose control strategies yielded mixed results for microvascular complications and did not appear to affect myocardial infarction rates in a new cohort study that followed patients over four years.

Patients report emotional factors play big role in glucose self-monitoring, survey suggests

For patients with type 2 diabetes, emotional factors may influence glucose self-monitoring behavior as much or more than practical factors, a new study suggests.

Higher glucose levels associated with dementia even in non-diabetic patients

Higher glucose levels may be a risk factor for dementia among patients with and without diabetes, a study found.

MKSAP Quiz: Lower hemoglobin A1c after surgery

This month's quiz asks readers to evaluate a 56-year-old man with type 2 diabetes in a follow-up after repair of a bleeding duodenal ulcer.

Telmisartan and valsartan associated with fewer hospitalizations for cardiovascular events than other ARBs, study finds

In patients with diabetes, telmisartan and valsartan were associated with lower rates of hospitalization for cardiovascular events than other angiotensin-receptor blockers (ARBs), according to a recent retrospective study.

Meta-analysis: Atorvastatin reduces CV events and increases new-onset diabetes in patients with coronary disease

In a meta-analysis, patients with two to four risk factors for diabetes were more likely to have new-onset diabetes if they took higher doses of statins.

What do I need to tell patients about hyperglycemia?

Patients with type 1 or 2 diabetes can benefit from advice about how to respond to episodes of hyperglycemia.

Hemoglobin A1c test approved for diagnosis

The FDA recently approved the first hemoglobin A1c (HbA1c) test specifically labeled for diagnosing diabetes.

Spotlight on hypoglycemia

The risks and consequences of hypoglycemia were described by several studies published recently.